The European Vaccine Initiative (EVI) is a leading European non-profit Product Development Partnership (PDP) that is supporting global efforts to develop effective and affordable vaccines against diseases of poverty and emerging infectious diseases.
The European Vaccine Initiative (EVI) supports global efforts to develop effective and affordable vaccines against diseases that disproportionately affect low- and middle-income countries. Through constructive collaboration and exchange with academia, pharmaceutical and biotechnology companies, policy makers, donors and other product development partnerships (PDPs), EVI is building a vaccine portfolio that proactively addresses critical challenges and opportunities, and is promoting innovative solutions in vaccine research and development (R&D).
EVI openly provides its expertise and supports vaccine R&D, helping them to advance and accelerate their vaccine candidates.
To contribute to global efforts to control diseases of poverty and emerging infectious diseases
A world free of the intolerable burden of diseases of poverty and emerging infectious diseases within the coming decades.
Our work is rooted in our commitment to the Sustainable Development Goals (SDGs) developed by the United Nations.
Immunisation increases school attendance and investment in education
Immunisation promotes health equity and reduces poverty
Good health & well-being
Immunisation prevents disease and disability; Eradicates diseases and protects communities
Decent Work & Economic Growth
Immunisation increases work productivity by improving physical or mental health
#VaccinesSaveLives #VaccinesForAll #HealthForAll
Learn more on the critical role of Immunisation in achieving 14 of 17 SDGs in the Immunization Agenda 2030: A Global Strategy to Leave No One Behind